Terms: = Pancreatic cancer AND NSD1, FLJ44628, 64324, ENSG00000165671, Q96L73, FLJ22263, DKFZp666C163, ARA267, STO, SOTOS
9 results:
1. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Singhal R; Rogers SC; Lee JH; Ramnaraign B; Sahin I; Fabregas JC; Thomas RM; Hughes SJ; Nassour I; Hitchcock K; Russell K; Kayaleh O; Turk A; Zlotecki R; DeRemer DL; George TJ
Future Oncol; 2023 Sep; 19(27):1841-1851. PubMed ID: 37753702
[TBL] [Abstract] [Full Text] [Related]
2. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract] [Full Text] [Related]
3. Role of nsd1 as potential therapeutic target in tumor.
Yang C; Wang K; Liang Q; Tian TT; Zhong Z
Pharmacol Res; 2021 Nov; 173():105888. PubMed ID: 34536546
[TBL] [Abstract] [Full Text] [Related]
4. Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine.
Tong Z; Yan C; Dong YA; Yao M; Zhang H; Liu L; Zheng Y; Zhao P; Wang Y; Fang W; Zhang F; Jiang W
BMC Med Genomics; 2020 Sep; 13(1):138. PubMed ID: 32957974
[TBL] [Abstract] [Full Text] [Related]
5. New Imidazo[2,1-
Li Petri G; Pecoraro C; Randazzo O; Zoppi S; Cascioferro SM; Parrino B; Carbone D; El Hassouni B; Cavazzoni A; Zaffaroni N; Cirrincione G; Diana P; Peters GJ; Giovannetti E
Anticancer Res; 2020 Sep; 40(9):4913-4919. PubMed ID: 32878779
[TBL] [Abstract] [Full Text] [Related]
6. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
Pandey A; Stawiski EW; Durinck S; Gowda H; Goldstein LD; Barbhuiya MA; Schröder MS; Sreenivasamurthy SK; Kim SW; Phalke S; Suryamohan K; Lee K; Chakraborty P; Kode V; Shi X; Chatterjee A; Datta K; Khan AA; Subbannayya T; Wang J; Chaudhuri S; Gupta S; Shrivastav BR; Jaiswal BS; Poojary SS; Bhunia S; Garcia P; Bizama C; Rosa L; Kwon W; Kim H; Han Y; Yadav TD; Ramprasad VL; Chaudhuri A; Modrusan Z; Roa JC; Tiwari PK; Jang JY; Seshagiri S
Nat Commun; 2020 Aug; 11(1):4225. PubMed ID: 32839463
[TBL] [Abstract] [Full Text] [Related]
7. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
8. Expression and prognostic value of nsd1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
Ettel M; Zhao L; Schechter S; Shi J
Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
[TBL] [Abstract] [Full Text] [Related]
9. Proliferation of gastrointestinal carcinoma cells by T lymphocyte factors interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dippold W; Meyer zum Büschenfelde KH
Immunol Res; 1991; 10(3-4):258-60. PubMed ID: 1955751
[TBL] [Abstract] [Full Text] [Related]